Aaron Wealth Advisors LLC Purchases 303 Shares of CME Group Inc. (NASDAQ:CME)

Aaron Wealth Advisors LLC lifted its position in CME Group Inc. (NASDAQ:CME) by 25.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,498 shares of the financial services provider’s stock after acquiring an additional 303 shares during the period. Aaron Wealth Advisors LLC’s holdings in CME Group were worth $331,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Capital International Investors boosted its stake in CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after acquiring an additional 3,069,806 shares in the last quarter. PineStone Asset Management Inc. boosted its position in shares of CME Group by 137.6% in the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock worth $444,443,000 after purchasing an additional 1,309,097 shares in the last quarter. M&G Plc purchased a new stake in shares of CME Group in the 1st quarter worth approximately $156,631,000. Assenagon Asset Management S.A. increased its position in CME Group by 577.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock valued at $126,872,000 after buying an additional 550,133 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its stake in CME Group by 11.3% during the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after buying an additional 537,758 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Activity

In related news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.

CME Group Stock Performance

Shares of CME opened at $228.32 on Friday. CME Group Inc. has a one year low of $190.70 and a one year high of $230.12. The stock has a 50-day moving average of $216.92 and a two-hundred day moving average of $208.34. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market cap of $82.21 billion, a P/E ratio of 25.97, a P/E/G ratio of 7.76 and a beta of 0.55.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same quarter last year, the firm posted $2.30 EPS. The business’s revenue was up 12.7% on a year-over-year basis. As a group, research analysts predict that CME Group Inc. will post 10.04 EPS for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were given a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.01%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s payout ratio is currently 52.33%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on CME shares. Piper Sandler increased their target price on CME Group from $225.00 to $240.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 8th. JPMorgan Chase & Co. raised their price objective on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. TD Cowen started coverage on shares of CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price on the stock. Royal Bank of Canada restated a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a report on Thursday, October 3rd. Finally, Keefe, Bruyette & Woods lifted their price objective on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $220.07.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.